Asia’s Leading ADC R&D & Manufacturing Conference – Uniting Asia Leaders in Antibody-Drug Conjugates market

23 - 24 March 2027 Sands Expo & Convention Centre, Singapore
Part of Biopharma APAC Confex 2027
Register Now
Co-located Events
BSCA 2027 (White) Visit Brochure
CTFA 2027 (White) Visit Brochure
BMA 2027 (White) Visit Brochure
CGTWA 2027 White Logo Visit Brochure
OPWA 2027 - White Logo Visit Brochure
Awards

About the Event

ADC Asia Congress 2027 is the region’s premier gathering dedicated to advancing Antibody-Drug Conjugates (ADCs), bringing together global innovators, biopharma leaders, researchers, manufacturers, investors, and solution providers from across the Asia-Pacific ecosystem. As ADCs continue to reshape the future of targeted cancer therapies, the congress serves as a strategic platform to explore the latest breakthroughs in discovery, conjugation technologies, payload development, manufacturing, clinical development, regulatory strategies, and commercialisation.

Designed to foster collaboration and accelerate innovation, the conference features high-level keynote presentations, technical case studies, panel discussions, and networking opportunities with leading pharmaceutical and biotechnology companies from across Asia and beyond. ADC Asia Congress 2027 offers attendees unparalleled access to industry insights, emerging trends, strategic partnerships, and business opportunities driving the next generation of precision medicine and oncology therapeutics.

What we'll cover

Key Themes

Asia’s Leadership in ADC Innovation
Highlighting Asia’s emergence as a global powerhouse in ADC R&D, fueled by biotech innovation, strategic partnerships, and late-stage clinical pipelines.
Next-Generation ADC Discovery & Design
Focus on pioneering novel targeting strategies, linker-payload technologies, and discovery platforms shaping the future of ADCs
Translational Excellence: From Bench to Bedside
Addressing the critical path from preclinical insights to successful clinical outcomes, and emphasizing safety, efficacy, and regulatory considerations.
Manufacturing, CMC & Quality Optimization
Showcasing innovative approaches in Chemistry, Manufacturing, and Controls (CMC), including process efficiency, quality control, and scale-up technologies.
Commercialization, Partnerships & Investment in Asia
Showcasing licensing, partnering, and funding strategies driving growth and commercialization success in the Asian ADC market.
BY THE NUMBERS

Our Impact in Asia's Biopharma

300+
Senior Attendees

Meet a highly concentrated audience of senior decision-makers, including VPs and Directors of ADC Early Development Bioconjugates/Bioconjugation, ADC Manufacturing & Process Development, Novel Modalities R&D, Heads of Toxicology and Pharmacokinetics, as well as Heads of Translational Medicine and Biology from leading biopharma hubs across the region.

100+
ADC Companies Represented

A high-level gathering of leading ADC developers, bioconjugation specialists, CDMOs, global biopharma players, innovative biotech companies, and technology providers across Asia’s key biopharma hubs.

40+
Expert Speakers

Hear from leading experts across Asia’s ADC landscape, including pioneers in ADC development, bioconjugation, manufacturing, process intensification, regulatory strategy, and next-generation therapeutic innovation. Gain insights from senior leaders driving advancement across the region’s top ADC companies and biopharma hubs.

Testimonials

Hear from past attendees and industry leaders

"The ADC Asia Congress provided an excellent platform for meaningful exchange. The strong emphasis on translating upstream innovation into manufacturing impact was particularly valuable."
Head of Biotherapeutics Process Development, Pharmaceutical Sciences
Takeda
Japan flag Japan
"It was a very valuable conference experience. The meeting offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections."
CTO
Singzyme
Singapore flag Singapore
"Great experience! Nice speakers and exhibitions!"
CEO
HoneyBear Biosciences, Inc.
Taiwan flag Taiwan
"Good selection of topics and speakers"
Senior Scientist, Bioprocessing Technology Institute
A*STAR
Singapore flag Singapore
"This 2nd ADC Asia Congress was well organized with lots of excellent speakers and informative materials. Well organized to ensure everyone in the ADC field to get to know the state of art in this fast growing field."
CEO
PinotBio
South Korea flag South Korea
"It was a fantastic experience speaking at the 2nd ADC Asia Congress. The event showcased cutting-edge advancements in the field and provided a valuable platform for meaningful discussions with key industry leaders. I look forward to seeing how this community continues to grow."
Senior Director and ADC MedChem Group Head
Innovent Biologics
China flag China

Sponsors & Media Partners

Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.

Silver Sponsor
BSP logo 1
Bronze Sponsors
Wuxi XDC_logo_4C
rest-nona-biosciences

2027 SPEAKERS

Simon Chuang
Simon Chuang
CEO
HoneyBear Science
Taiwan flag Taiwan
Bin Zou
Bin Zou
CEO & Founder
Axcynsis Therapeutics
Singapore flag Singapore
Won Gyun Ahn
Won Gyun Ahn
Associate Director
Qurient
South Korea flag South Korea
Doo Young Jung
Doo Young Jung
Chief Executive Officer
PinotBio
South Korea flag South Korea

AGENDA AT A GLANCE

CONFERENCE DAY 1 | 23rd March 2027
CONFERENCE DAY 2 | 24th March 2027
Leadership Panel Discussion
Building Asia’s Global Leadership in ADCs
Advancing Payloads and Linker Technologies for Next-Generation ADCs
Morning Break – Exhibition Viewing & 1-1 Attendees Networking
Discovery
Innovative Pathways in ADC Discovery: Unlocking Next-Gen Targeting Strategies
Safety and Efficacy
Balancing Safety and Efficacy in ADCs: Overcoming Challenges for Effective Treatment
Lunch – Exhibition Viewing & 1-1 Attendees Networking
Advancing Pre-Clinical Research
Bringing the Gap: From Pre-Clinical Insights to Clinical Success in ADC Development
ADC Biopharma Showcase
Pioneering Innovation and Excellence in Antibody-Drug Conjugates
Afternoon Break – Exhibition Viewing & 1-1 Attendees Networking
Formulation & Stability
Ensuring ADC Stability & Optimized Formulation for Maximum Efficacy
Asia-Pacific Biopharma Excellence Awards 2027
CONFERENCE DAY 1 | 23rd March 2027
Leadership Panel Discussion
Building Asia’s Global Leadership in ADCs
Morning Break – Exhibition Viewing & 1-1 Attendees Networking
Discovery
Innovative Pathways in ADC Discovery: Unlocking Next-Gen Targeting Strategies
Lunch – Exhibition Viewing & 1-1 Attendees Networking
Advancing Pre-Clinical Research
Bringing the Gap: From Pre-Clinical Insights to Clinical Success in ADC Development
Afternoon Break – Exhibition Viewing & 1-1 Attendees Networking
Formulation & Stability
Ensuring ADC Stability & Optimized Formulation for Maximum Efficacy
Asia-Pacific Biopharma Excellence Awards 2027
CONFERENCE DAY 2 | 24th March 2027
Advancing Payloads and Linker Technologies for Next-Generation ADCs
Safety and Efficacy
Balancing Safety and Efficacy in ADCs: Overcoming Challenges for Effective Treatment
ADC Biopharma Showcase
Pioneering Innovation and Excellence in Antibody-Drug Conjugates
Apply to Speak
CONFERENCE AGENDA

Day 1

23 March 2027

8:50
Chairman Opening Remarks
9:00
Panel Discussion: Platform to Pipeline: What It Takes to Win in APAC's ADC Race
  • Comparing conjugation and payload strategies driving differentiation among leading APAC ADC platforms
  • Navigating licensing, out-licensing, and Western partnership deals from a China/APAC vantage point
  • Scaling from platform validation to clinical and manufacturing readiness in a capacity-constrained market
9:25
Accelerating Development Timelines: Innovative Technologies for ADCs
  • Showcasing next-generation technologies enabling faster process development and optimization.
  • Exploring advanced analytical tools for improving product characterization and quality control.
  • Examining innovations in conjugation, formulation, and delivery technologies for ADCs and novel therapeutics.
  • Discussing how technology providers and CDMOs can support rapid clinical and commercial manufacturing.
Reserved for Solution Provider
9:50
Advancing ADC Development: Enhancing Speed, Quality and Commercial Readiness
  • Implementing platform-based approaches to accelerate ADC development timelines.
  • Improving cell line development, process development, and analytical characterization strategies.
  • Balancing innovation, cost-efficiency, and regulatory compliance throughout product development.
10:30
Morning Break – Exhibition Viewing & 1-1 Networking
11:15
Innovative Linker Strategies: Improving Stability and Tumor-Specific Activation
  • pH-sensitive and enzymatically cleavable linkers for targeted release
  • Strategies to minimize systemic toxicity and maximize drug release efficiency
  • Engineering linkers to overcome multi-drug resistance in tumors
11:40
Overcoming ADC Resistance: Strategies for Enhancing Tumor Cell Killing
  • Mechanisms of resistance: ADC efflux, antigen loss, and lysosomal degradation
  • Combination therapies: ADCs with checkpoint inhibitors and targeted therapies
  • Approaches to optimize ADC recycling and increase intracellular payload delivery
Reserved for Solution Provider
12:05
Targeted Immune-Stimulatory Payloads: Harnessing the Immune System for ADC Therapy
  • Using ADCs to deliver immune-activating molecules directly to tumors
  • Payloads designed to stimulate T cells, NK cells, or macrophages in the tumor microenvironment
  • Combination strategies with immune checkpoint inhibitors to enhance anti-tumor responses
12:30
Lunch – Exhibition Viewing & 1-1 Networking
2:15
Advancing Clinical Progress of Next-Generation ADC Pipelines in East Asia
  • Sharing latest clinical trial updates and milestones from ongoing ADC programmes in East Asia
  • Highlighting early efficacy, safety, and translational data across solid tumour and haematology indications
  • Discussing regulatory pathways and strategies to accelerate ADC approvals in Asia and global markets
2:40
The Next Wave of ADC Approvals: Key Learnings from Recent FDA and EMA Submissions
  • Clinical trial design strategies that accelerate ADC approval
  • Overcoming safety concerns: Managing off- target toxicity
  • Case studies of recent successful ADC approvals and regulatory hurdles
Reserved for Solution Provider
3:20
Translating ADC Innovation into Clinical Success Across East Asia
  • Showcasing breakthrough clinical achievements and first-in-human data from East Asian biopharma companies
  • Sharing lessons learned from ADC clinical development, manufacturing readiness, and global partnering efforts
  • Evaluating the future landscape of ADC therapeutics including dual payloads, novel targets, and next-generation conjugation platforms
3:45
Afternoon Break – Exhibition Viewing & 1-1 Networking
4:15
Purification and Analytical Strategies for High-Quality ADCs
  • Advanced purification approaches to remove aggregates and free payloads
  • Analytical methods for characterization: DAR, stability, and impurity profiling
  • Addressing scalability challenges in downstream processing
4:40
Linker Innovation: Enhancing Stability and Controlled Drug Release
  • Cleavable vs non-cleavable linkers: design considerations and trade-offs
  • Tumor-selective release mechanisms and microenvironment triggers
  • Improving plasma stability to reduce systemic toxicity
4:55
Optimizing Payload-Linker Integration for Superior ADC Performance
  • Synergizing linker and payload design to maximize therapeutic index
  • Impact of conjugation chemistry on payload delivery and efficacy
  • Translational insights from preclinical optimization to clinical outcomes
5:20
Chairman Closing Remarks
5:25
End of Conference Day 1
6:00
ABEA Awards 2027
CONFERENCE AGENDA

Day 2

24 March 2027

8:55
Chairman Opening Remarks
9:00
Enhancing ADC Yield and Consistency: Advances in Bioconjugation Technologies
  • Site-specific vs. random conjugation: Impact on ADC stability and efficacy
  • Al-driven process optimization for consistent drug-to-antibody ratio (DAR)
  • Novel bioconjugation chemistries to improve homogeneity
9:25
Engineering Beyond the First Wave of Next-Gen ADCs
  • Emerging conjugation and linker chemistries pushing past current DAR and stability limitations
  • Novel payload classes beyond topoisomerase inhibitors and their differentiated mechanisms of action
  • Adjacent modalities: bispecific ADCs, degrader-conjugates, and immune-stimulating payloads reshaping the pipeline
10:15
Purification and Formulation Strategies for ADC Manufacturing
  • Addressing aggregation and stability challenges during ADC purification
  • Advances in chromatography techniques for high-purity ADC isolation
  • Lyophilization and storage considerations for long-term ADC stability
10:30
Morning Break – Exhibition Viewing & 1-1 Networking
11:15
Enhancing ADC Performance: Tackling Toxicity and Resistance
  • Addressing dose-limiting toxicities in clinical settings
  • Overcoming resistance through novel design approaches
  • Role of dual payloads and combination strategies
11:40
Enhancing ADC Yield and Consistency: Advances in Bioconjugation Technologies
  • Site-specific vs. random conjugation: Impact on ADC stability and efficacy
  • Al-driven process optimization for consistent drug-to-antibody ratio (DAR)
  • Novel bioconjugation chemistries to improve homogeneity
Reserved for Solution Provider
12:05
Enhancing ADC Performance: Tackling Toxicity and Resistance
  • Addressing dose-limiting toxicities in clinical settings
  • Overcoming resistance through novel design approaches
  • Role of dual payloads and combination strategies
12:30
Lunch – Exhibition Viewing & 1-1 Networking
2:10
Clinical Development Updates and Future Directions for Emerging ADC Therapies
  • Presenting Phase I–III clinical progress and pipeline expansion strategies for novel ADC candidates
  • Exploring patient selection, biomarker strategies, and combination therapy approaches in clinical studies
  • Addressing key challenges in dose optimisation, toxicity management, and clinical differentiation
2:35
Dual-Targeting and Bispecific ADCs: Enhancing Tumor Selectivity
  • Development of bispecific ADCs to improve tumor penetration
  • Addressing tumor heterogeneity with dual- antigen recognition
  • Engineering strategies to reduce off-target effects
Reserved for Solution Provider
2:50
Leadership Panel Discussion: Current Market Trends and Future Directions for ADCs
  • Expanding ADC applications beyond oncology: Autoimmune diseases and infectious diseases
  • Investment trends in ADC biotech startups and big pharma partnerships
  • Navigating global regulatory requirements: Differences in approval pathways
3:15
Afternoon Break – Exhibition Viewing & 1-1 Networking
5:20
End of Conference Day 2

Awards & Recognition

Asia-Pacific Biopharma Excellence Awards 2027
23rd March 2027Sands Expo & Convention Centre, Singapore
The Asia-Pacific Biopharma Excellence Awards (ABEA) 2027 aims to honour exceptional achievements in the Asian biopharma sector, recognizing excellence in bioprocessing, logistics and supply chain management, antibody-drug conjugates (ADC), and clinical trials over the past year. Celebrating the remarkable contributions of leading biopharma professionals, organizations, and technologies, the awards spotlight trailblazing leaders and trendsetters shaping the industry's future while inspiring innovation for tomorrow’s biopharma landscape.
Learn More About Our Awards
By Profile
Asian Biopharma
35%
International Biopharma
25%
CDMOs & CROs
20%
Academic & Research Institutes
10%
Technology & Service Providers
10%
By Job Title
VP & Directors of ADC Early Development Bioconjugates/ Bioconjugation
20%
VP & Directors of ADC Manufacturing & Process Development
20%
VPs & Directors, Novel Modalities R&D, Heads of Toxicology/Pharmacokinetics
15%
Head of Translational Medicine and Biology
15%
QA & QC
15%
Business Development & Marketing
15%
By Geography
World Map
20%
South Korea & Japan
20%
China, Taiwan & Hong Kong
20%
Singapore
15%
Indonesia, Thailand, India & Malaysia
20%
USA & Europe
5%
Australia
20%
South Korea & Japan
20%
China, Taiwan & Hong Kong
20%
Singapore
15%
Indonesia, Thailand, India & Malaysia
20%
USA & Europe
5%
Australia

Who Should Sponsor?

LINKER & PAYLOAD DEVELOPMENT
PROCESS DEVELOPMENT & CDMOS
FORMULATION DEVELOPMENT
BIOCONJUGATION CHEMISTRY
REGULATORY SUPPORT
BIOINFORMATICS & COMPUTATIONAL MODELLING
PRE-CLINICAL DEVELOPMENT & CLINICAL TRIAL SUPPLY & MANAGEMENT & CROS
FILL-FINISH PACKAGING
CDMOS, CROS & ADC SERVICE PROVIDERS
ANALYTICAL TESTING & QUALITY CONTROL
SPONSORSHIP BENEFITS

Why Sponsor This Event?

Thought Leadership

Present Your Expertise to the Biopharma Industry's Key Stakeholders through a Variety of Available Speaking Packages.

Host a Panel Discussion

Moderate a panel discussion including one representative from your company with 3 representatives from the end user side to share views on a current industry topic

Duration: 45 minutes

Showcase Your Solutions to Educate the Market

Join in for dedicated CMO & CRO Showcases

Branding

Emphasize on your Message by Marketing and Promoting Alongside the Event

Networking & Lead Generation

Gain Exclusive Access to Contacts of High Profile Attendees through Intimate Networking Opportunities

Our Past Partners

SCHOTT AG
Acro Biosystems
Wuxi XDC_logo_4C
LabCorp_logo
Huida Biotech
Sartorius Logo
Asymbio
Asymchem_Logo
sigma-aldrich
BSP logo 1
Becton_Dickinson_logo.svg
IDBS_Logo
WuXi Biologics
Merck
solventum-logo-horz-clr-pos-rgb
Pfanstiehl-hd
DYE logo blue 1
Aurigene
lonza
cytiva-logo-vector
avantor-inc-logo-vector
Charles_River_Laboratories_Logo.svg
Truking logo 1
cellist-1
watson-marlow (1)
Aber
Single Use Support
PharmNXT Logo_COLOUR_transparent 2K
Tosoh Bioscience
Emerson_Electric_Company
Dr Paul Lohman
avantor-inc-logo-vector
Genscript GS_Logo_Primary_RGB
Shimadzu 1
Tofflon
Jiuzhou
IKA_Logo
Gerresheimer 2
Imalife
Lisure Science
Ellab_Logo_tagline_CYAN 2_page-0001
airdynamics
unither-pharma
ATUM_RGB_Black 1
Sanisure
SHENTEK logo
Duoning-Logo-EN-small-1
Evonik
Biomed Logo (Dark Blue & Light Blue) (1) (1)
novo-nordisk
SGS_Logo.svg
Sphere Bio-use this Dark Green WSTB Primary@300x-8 1
Biohaus Media (Media Partner) Logo
BioPharma Asia Logo
Agilent-Logo-Site
Refeyn-01
and many more...
PARTNER WITH US

Sponsorship Packages

Tailored sponsorship opportunities designed to maximize your brand visibility and lead generation.

Platinum Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 20 min (+ 5 min live Q&A). In the main conference sessions.
  • 1 End-user client case study: 20 min (+ 5 min live Q&A). Complimentary, in the main conference sessions.
  • 1 Pre-conference workshop: Half day (catered for 30 pax). Room hire and one refreshment included. Limited to 1 - 2 sponsors.
  • 1 Conference chairmanship: Day 2. Optional and subject to availability.
  • 1 Pre-event speaker interview. Shared with the ADC community and on social media.

Exhibition

  • 1 Exhibition space: 12 sqm (6 × 2 m table-top, upgrade to 18 sqm). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 7 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.
  • 5 1:1 meeting assistance. Help setting up meetings on site with targeted companies.

Branding & reach

  • 1 Logo placement: Priority. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 200 words. Maximum length, on the official event web page.
  • 1 Brochure distribution. At the registration desk or conference table.
  • 1 Corporate gift distribution. Optional.
  • 1 In-depth post-event report. Exclusive to sponsors.
Gold Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 20 min (+ 5 min live Q&A). In the main conference sessions.
  • 1 Panel or roundtable moderator. Complimentary.
  • 1 Pre-event speaker interview. Shared with the ADC community and on social media.

Exhibition

  • 1 Exhibition space: 9 sqm (4.5 × 2 m table-top, upgrade to 12 sqm). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 6 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.
  • 5 1:1 meeting assistance. Help setting up meetings on site with targeted companies.

Branding & reach

  • 1 Logo placement: Priority. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 150 words. Maximum length, on the official event web page.
  • 1 Brochure distribution. At the registration desk or conference table.
  • 1 Corporate gift distribution. Optional.
  • 1 In-depth post-event report. Exclusive to sponsors.
Silver Sponsor (Enhanced)

Speaking & thought leadership

  • 1 Conference presentation: 25 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top, upgrade to 9 sqm booth). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 4 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners. Credited as Silver Sponsor.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Silver Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 15 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 3 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Bronze Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 15 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 1 sqm (upgrade to 6 sqm for first-time clients). In the Exhibition Hall. All upgrades are complimentary. Space for a banner display and/or a small networking table. The upgrade, to a 3 × 2 m table-top, is a one-time offer.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 1 Conference passes. Premium conference sessions and the Exhibition Hall.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Exhibitor

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 2 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Promotional video: 1 - 2 min. Played in the ad slots across both event days.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.

Be a Part of This Event!

Don't miss out on unique networking, speaking and sponsorship opportunities.

Register Here!
Portfolio Specialist
Nurul Hafifa
+65 6371 9704
Business Development Manager
Ana Laxamana
+65 6983 6132